Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates

Therapeutic Drug Monitoring
Joyce PullenLuc J I Zimmermann

Abstract

Amoxicillin plasma concentrations, pharmacokinetic parameters, and the influence of demographic, anthropometric, and clinical covariates were investigated in 150 neonates. Gestational age (GA) ranged from 25 to 42 weeks and mean postnatal age (PNA) was 0.8 days. Amoxicillin concentrations were measured with reversed-phase HPLC in surplus plasma from routine assays of coadministered gentamicin. Mean total body clearance corrected for body weight (CL/W) was 0.096 +/- 0.036 L/kg(-1)h(-1), mean elimination half-life (t(1/2)) was 5.2 +/- 1.9 hours, and mean volume of distribution corrected for body weight (V/W) was 0.65 +/- 0.13 L/kg. Multiple regression equations were calculated for the prediction of CL/W amoxicillin. CL/W gentamicin, V/W gentamicin, and GA were significant predictors of CL/W amoxicillin. Amoxicillin peak and trough concentrations after the second dose and the time the concentration exceeds the minimum inhibitory concentration (T>MIC), reached with the current dosage regimen, were evaluated. Toxic plasma concentrations were reached in several patients. Therefore, the authors have proposed a lower dosage regimen, based on GA, population pharmacokinetic parameters, bacterial susceptibility (T>MIC), and possible toxic...Continue Reading

References

Jan 1, 1989·Clinical Pharmacokinetics·P L Morselli
Apr 1, 1974·The Journal of Pediatrics·J M KaplanN Davis
Feb 1, 1995·Antimicrobial Agents and Chemotherapy·J J Huisman-de BoerR de Groot
Dec 1, 1993·Clinical Pediatrics·D P JonesF B Stapleton
Dec 1, 1993·Social Science & Medicine·D C Wertz, J C Fletcher
Dec 31, 1997·Journal of Pharmaceutical Sciences·B G CharlesN Debuse
Apr 30, 1998·The Annals of Pharmacotherapy·C L ShafferP Gal
Apr 2, 1999·Pediatrics·J P Guignard, A Drukker
Sep 24, 1999·Drugs·V Fanos, A Dall'Agnola
Aug 9, 2003·BMJ : British Medical Journal·Edmund Hey
Aug 26, 2003·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jody Hey
Oct 29, 2003·Paediatric Drugs·Robert S Baltimore
Nov 7, 2003·Archives of Disease in Childhood. Fetal and Neonatal Edition·P W Fowlie, P G Davis
Feb 11, 2005·Seminars in Fetal & Neonatal Medicine·Matthijs de HoogJohn N van den Anker

❮ Previous
Next ❯

Citations

Sep 24, 2008·European Journal of Clinical Pharmacology·G M PacificiI Choonara
Nov 28, 2012·Clinical Pharmacokinetics·Amélie MarsotNicolas Simon
Oct 29, 2008·Antimicrobial Agents and Chemotherapy·Maurice J AhsmanRon A Mathot
Oct 8, 2011·Expert Review of Clinical Pharmacology·Matthew M LaughonMichael Cohen-Wolkowiez
Apr 4, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A van BoekholtB Semmekrot
Aug 5, 2015·Journal of Chemotherapy·Gian Maria Pacifici, Karel Allegaert
Jul 22, 2014·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Alan R Schroeder, Shawn L Ralston
Mar 3, 2007·Clinical Pharmacology and Therapeutics·M A AndrewM F Hebert
Sep 25, 2018·Journal of Clinical Pharmacology·Stephen J Balevic, Michael Cohen-Wolkowiez
Sep 4, 2018·British Journal of Clinical Pharmacology·Dagan O LonsdaleJoseph F Standing
Jun 17, 2006·Therapeutic Drug Monitoring·Joyce PullenLuc J I Zimmermann
Dec 14, 2006·Therapeutic Drug Monitoring·John N van den Anker
Dec 5, 2018·Antimicrobial Agents and Chemotherapy·Bo-Hao TangWei Zhao
May 29, 2007·Therapeutic Drug Monitoring·J PullenL J I Zimmermann
Jul 3, 2007·Biomedical Chromatography : BMC·J PullenL J I Zimmermann
May 31, 2017·Clinical Pharmacology and Therapeutics·Y A BijleveldUNKNOWN PharmaCool Study Group
Oct 1, 2020·Journal of Clinical Pharmacology·Yue-E WuWei Zhao
May 15, 2020·Archives of Disease in Childhood·Fatima MirAnita Km Zaidi
Oct 30, 2020·Frontiers in Pharmacology·Salvatore D'AgateOscar Della Pasqua
Apr 30, 2014·Pediatrics·John S BradleyUNKNOWN AAP Committee on Infectious Diseases and Disaster Preparedness Advisory Council

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Therapeutic Drug Monitoring
Joyce PullenLuc J I Zimmermann
Antimicrobial Agents and Chemotherapy
Adriana TremouletAdministrative Core Committee of the Best Pharmaceuticals for Children Act-Pediatric Trials Network
La Pediatria medica e chirurgica : Medical and surgical pediatrics
R RondanelliG Rondini
© 2022 Meta ULC. All rights reserved